On December 29, Shukun technology, an artificial intelligence medical platform, signed a strategic cooperation agreement with Meinian Onehealth Healthcare Holdings Co.Ltd(002044) in Beijing. The two sides will carry out in-depth cooperation around early screening of chronic diseases and health management, and work together to create a new era of “intelligent health management”. Shukun technology will apply the global original AI technology and “healthy digital doctor” products to intelligently upgrade the health examination and medical institutions under Meinian Onehealth Healthcare Holdings Co.Ltd(002044) group all over the country, and promote the full implementation of the application scenario of “intelligent health management”.
Public information shows that Shukun technology is an artificial intelligence medical technology platform enterprise, and its “digital doctor” product portfolio includes 12 products and 25 candidate products. The digital doctor products of Shukun technology have been used in more than 1600 hospitals in China, with a total service of more than 100 million person times, increasing at a rate of 10% per month, of which the coverage rate of class III hospitals has reached 40%. The goal of its intelligent health management is: from the physical examination and medical services of early diagnosis and early treatment to the protection and care of human beings in the whole life cycle. In the future, everyone will have a digital human body, record the changes of human health in real time, and be escorted by digital doctors.
Up to now, Shukun technology has obtained 2 class III medical device registration certificates of the State Drug Administration (nmpa), 11 class II medical device registration certificates of nmpa and 4 MDR CE certification. Shukun technology is not only the Chinese medical AI enterprise with the largest number of EU MDR CE certification, but also its coronary heart disease and stroke related AI products are the only original medical AI products with EU CE certification for similar products in China.
Meinian Onehealth Healthcare Holdings Co.Ltd(002044) is the largest leading non-public physical examination enterprise in China, including four brands of “meinian great health”, “Ciming”, “AoYa” and “meizhao”. The company has arranged 607 physical examination centers in more than 300 cities across the country, and the number of physical examinations reaches nearly 30 million person times every year. Meinian Onehealth Healthcare Holdings Co.Ltd(002044) its subsidiaries in Shanghai, Hangzhou, Wuhan and other places have successively signed contracts with the third class hospitals to build a medical consortium, participated in the mutual recognition of test results by local health administrative departments, and has been incorporated into the local mutual recognition system.
Meinian Onehealth Healthcare Holdings Co.Ltd(002044) from the leader of physical examination to the medical mutual recognition system, and Shukun technology from medical auxiliary diagnosis to the health management system. The two leading enterprises in their respective segments have reached strategic cooperation under the background of promoting the implementation of the “healthy China” strategy. At present, the “cardiopulmonary screening” and other projects of Shukun technology have been carried out in the physical examination institutions under Meinian Onehealth Healthcare Holdings Co.Ltd(002044) group. With the continuous development of cooperation, there will be more “Health Digital doctors” products to reshape the new pattern of health management industry. In the future, the two sides will further increase the layout and application of artificial intelligence innovative technologies, generate more value through technological empowerment, and build a solid foundation for effective disease screening.
(Shanghai Securities News · China Securities Network)
